Suppr超能文献

挪威髋关节骨折和其他骨质疏松症药物使用预测因子。

Hip fracture and other predictors of anti-osteoporosis drug use in Norway.

机构信息

Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.

出版信息

Osteoporos Int. 2013 Apr;24(4):1225-33. doi: 10.1007/s00198-012-2063-1. Epub 2012 Jul 10.

Abstract

UNLABELLED

This study aims to find predictors of anti-osteoporosis drug (AOD) use. Known risk factors of osteoporosis, i.e., age, hip fracture, and corticosteroid use were found to be predictors of AOD use, in addition to a number of other drugs used. Higher socioeconomic position did not favor the use of AOD.

INTRODUCTION

This study deals with studying predictors of anti-osteoporosis drug treatment in Norwegian women and men.

METHODS

All Norwegian women and men≥50 years were included (n=1,407,392). Data were taken from different data sources, (1) the Norwegian Prescription Database (drug use in 2004-2005); (2) the Nationwide Census 2001 (marital status, education and resident county); (3) the National Hip Fracture Database (hip fractures 2003-2005); and (4) the National Population Register (date of death/emigration). We estimated the hazard ratios (HR) for incident treatment by Cox proportional hazard regression.

RESULTS

In 2005, 10,332 women (1.5%) and 1,387 men (0.2%) were new users of anti-osteoporosis drugs (incident treatment). Age was a statistically significant predictor of incident treatment in both women and men, with HR ranging from 1.7 to 3.2 (per 10 years). A middle educational level in men strongly predicted incident treatment [HR 2.0 (CI 1.1-3.8)], but not in women after full adjustment. A previous hip fracture, increasing number of drugs used and use of corticosteroids were all predictors of incident treatment in both genders after adjustments. Corticosteroid use [HRwomen=4.0 (CI 3.8-4.2)] had a higher HR for incident treatment than hip fracture [HRwomen=2.0 (CI 1.8-2.3)]. Marital status and area of residency were not predictors of incident treatment in either gender, after adjustments. The predictors of prevalent treatment were only slightly different from incident treatment in 2005.

CONCLUSIONS

Age, previous hip fracture, number of drugs used, and use of corticosteroids were positively related to treatment in both genders. In men, a middle educational level predicted treatment.

摘要

本研究旨在寻找抗骨质疏松药物(AOD)使用的预测因素。除了一些其他药物外,已知的骨质疏松风险因素,如年龄、髋部骨折和皮质类固醇的使用,也被发现是 AOD 使用的预测因素。较高的社会经济地位并不能促进 AOD 的使用。

引言

本研究涉及研究挪威女性和男性中抗骨质疏松药物治疗的预测因素。

方法

所有≥50 岁的挪威女性和男性(n=1,407,392)均纳入研究。数据来自不同的数据来源:(1)挪威处方数据库(2004-2005 年药物使用情况);(2)全国普查 2001 年(婚姻状况、教育程度和居住县);(3)全国髋部骨折数据库(2003-2005 年髋部骨折);(4)全国人口登记册(死亡/移民日期)。我们使用 Cox 比例风险回归估计了新发病例治疗的风险比(HR)。

结果

2005 年,10332 名女性(1.5%)和 1387 名男性(0.2%)开始使用抗骨质疏松药物(新发病例治疗)。年龄是女性和男性新发病例治疗的统计学显著预测因素,风险比范围为 1.7 至 3.2(每 10 年增加 10 年)。男性中等教育程度强烈预测新发病例治疗[HR2.0(CI1.1-3.8)],但在充分调整后,女性则不然。既往髋部骨折、使用药物数量增加和皮质类固醇的使用均为两性新发病例治疗的预测因素,调整后。皮质类固醇的使用[HRwomen=4.0(CI3.8-4.2)]比髋部骨折[HRwomen=2.0(CI1.8-2.3)]对新发病例治疗的 HR 更高。婚姻状况和居住地区在调整后均不是两性新发病例治疗的预测因素。2005 年,现有治疗的预测因素与新发病例治疗仅略有不同。

结论

年龄、既往髋部骨折、使用药物数量和皮质类固醇的使用与两性治疗均呈正相关。在男性中,中等教育程度预测治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验